Jie Wei Zhu

ORCID: 0000-0001-7251-8114
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dermatology and Skin Diseases
  • Pancreatic and Hepatic Oncology Research
  • Food Allergy and Anaphylaxis Research
  • Breast Cancer Treatment Studies
  • Cancer Genomics and Diagnostics
  • Allergic Rhinitis and Sensitization
  • Heart Failure Treatment and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Brain Metastases and Treatment
  • Renal cell carcinoma treatment
  • Gallbladder and Bile Duct Disorders
  • Global Cancer Incidence and Screening
  • Pancreatitis Pathology and Treatment
  • Genetic factors in colorectal cancer
  • Sex and Gender in Healthcare
  • Gastrointestinal motility and disorders
  • Ovarian cancer diagnosis and treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Nail Diseases and Treatments
  • Gastrointestinal disorders and treatments
  • Full-Duplex Wireless Communications
  • Diagnosis and Treatment of Venous Diseases
  • Cancer and Skin Lesions
  • Diabetes Management and Research
  • PARP inhibition in cancer therapy

University of Toronto
2022-2024

Ningbo Medical Center Lihuili Hospital
2020-2024

Ningbo University
2024

Chongqing University
2024

Chongqing Emergency Medical Center
2024

Women's College Hospital
2022-2023

McMaster University
2020-2023

Changsha Environmental Protection College
2022

Hamilton Health Sciences
2020-2021

Chengdu University of Traditional Chinese Medicine
2020

Heart failure has a disproportionate burden on patients who are Black, Indigenous, and people of color (BIPOC), but not much is known about representation these groups in randomized controlled trials (RCTs). We explored temporal trends RCT factors associated with the reporting race ethnicity data enrollment BIPOC heart RCTs.We searched MEDLINE, EMBASE, CINAHL for RCTs published journals an impact factor ≥10 between January 1, 2000 June 17, 2020. used Cochran-Armitage Jonchkeere-Terpstra...

10.1161/circheartfailure.121.008685 article EN Circulation Heart Failure 2021-12-16

Ovarian cancer has a high case fatality rate, but patients who have no visible residual disease after surgery relatively good prognosis. The presence of any cells left in the peritoneal cavity treatment may precipitate recurrence. In many cases, these are occult and not to surgeon. Analysis circulating tumour DNA blood (ctDNA) offer sensitive method predict (non-visible) help We assessed 48 women diagnosed with serous ovarian (47 high-grade 1 low-grade) for ctDNA. Plasma, formalin-fixed...

10.3390/ijms241814388 article EN International Journal of Molecular Sciences 2023-09-21

We introduce MiniMax-01 series, including MiniMax-Text-01 and MiniMax-VL-01, which are comparable to top-tier models while offering superior capabilities in processing longer contexts. The core lies lightning attention its efficient scaling. To maximize computational capacity, we integrate it with Mixture of Experts (MoE), creating a model 32 experts 456 billion total parameters, 45.9 activated for each token. develop an optimized parallel strategy highly computation-communication overlap...

10.48550/arxiv.2501.08313 preprint EN arXiv (Cornell University) 2025-01-14

Brain metastases (BrM) are most common among patients with metastatic lung cancer, breast and melanoma. Historically, management of BrM consisted local treatments surgical resection and/or radiation therapy, either whole brain therapy (WBRT) or stereotactic radiosurgery (SRS). Current guidelines recommend SRS as the initial for who have up to four BrM, but several studies demonstrated that upfront may be considered some more than given additional clinical benefits improved memory function...

10.58931/cot.2025.2132 article EN Canadian oncology today. 2025-04-11

Abstract Background The purpose of this study is to examine and analyse the outcomes patient experiences associated with laparoscopic central pancreatectomy. Methods perioperative data 16 patients who underwent pancreatectomy were retrospectively analysed at Ningbo Medical Center Lihuili Hospital (Xingning Branch Eastern Branch) from September 2017 July 2023. Results All surgical procedures completed without need for intraoperative conversion open surgery. In two cases, cholangiography was...

10.1111/ans.18893 article EN cc-by ANZ Journal of Surgery 2024-02-02

Abstract Introduction: Pancreaticojejunostomy have been studied and modified for more than a hundred years. We investigated new method of pancreaticojejunostomy to explore its value in laparoscopic pancreaticoduodenectomy. Patients Methods: A retrospective analysis was conducted on the clinical data 93 patients who underwent pancreaticoduodenectomy with ‘Shunt-block combined’ at Ningbo Medical Center Lihuili Hospital from April 2017 February 2023. Results: All successfully completed surgery,...

10.4103/jmas.jmas_59_24 article EN cc-by-nc-sa Journal of Minimal Access Surgery 2024-07-01

Background and objectives: Previous studies have shown that deep brain stimulation can improve clinical symptoms in patients with mild Alzheimer’s disease, but the therapeutic effect moderate-to-severe disease remains unclear. Therefore, we intend to assess of on through a 24-month follow-up visit.Design: A prospective single-center, self-controlled study.Methods: This trial will be performed at 101st Hospital PLA, Wuxi, China. We include 20 who given bilateral via an implant located beside...

10.4103/2542-3975.235150 article EN Clinical Trials in Degenerative Diseases 2018-01-01

: Merkel cell carcinoma (MCC) is a rare but aggressive neuroendocrine tumour of the skin. MCC second most common cause death from non-melanoma skin cancer and cutaneous malignancy. An 88-year-old male presented with large, bleeding located on right temple pre-auricular region. A biopsy confirmed MCC; immunohistochemistry (IHC) was positive for synaptophysin CK20. The patient assessed by head neck surgical oncologist not deemed to have operable disease due medical co-morbidities extent...

10.21037/apm-20-258 article EN Annals of Palliative Medicine 2020-06-11
Coming Soon ...